カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界のエルシニア症治療用抗生物質市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Antibiotics for Yersiniosis Treatment Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19141）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19141
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：96
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界のエルシニア症治療用抗生物質市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

エルシニア症治療用抗生物質市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のエルシニア症治療用抗生物質の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

エルシニア症治療用抗生物質市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・アミノ配糖体、トリメトプリム・スルファメトキサゾール、その他

用途別セグメントは次のように区分されます。
・病院、診療所、その他

世界のエルシニア症治療用抗生物質市場の主要な市場プレーヤーは以下のとおりです。
・Pfizer、Roche、Teva、Virchow Laboratories、Zhendong Group、Datong Wuzhou Tong、PKU HealthCare Corp.、Jilin Wantong、Zhejiang Jinhua CONBA Bio-pharm

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、エルシニア症治療用抗生物質製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なエルシニア症治療用抗生物質メーカーの企業概要、2019年～2022年までのエルシニア症治療用抗生物質の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なエルシニア症治療用抗生物質メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別エルシニア症治療用抗生物質の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのエルシニア症治療用抗生物質の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのエルシニア症治療用抗生物質市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびエルシニア症治療用抗生物質の産業チェーンを掲載しています。
・第13、14、15章では、エルシニア症治療用抗生物質の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- エルシニア症治療用抗生物質の概要
- 種類別分析（2017年vs2021年vs2028年）：アミノ配糖体、トリメトプリム・スルファメトキサゾール、その他
- 用途別分析（2017年vs2021年vs2028年）：病院、診療所、その他
- 世界のエルシニア症治療用抗生物質市場規模・予測
- 世界のエルシニア症治療用抗生物質生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Pfizer、Roche、Teva、Virchow Laboratories、Zhendong Group、Datong Wuzhou Tong、PKU HealthCare Corp.、Jilin Wantong、Zhejiang Jinhua CONBA Bio-pharm
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：アミノ配糖体、トリメトプリム・スルファメトキサゾール、その他
・用途別分析2017年-2028年：病院、診療所、その他
・エルシニア症治療用抗生物質の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・エルシニア症治療用抗生物質のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・エルシニア症治療用抗生物質のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・エルシニア症治療用抗生物質の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・エルシニア症治療用抗生物質の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Antibiotics for Yersiniosis Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Antibiotics for Yersiniosis Treatment market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospitals accounting for % of the Antibiotics for Yersiniosis Treatment global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Aminoglycosides segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Antibiotics for Yersiniosis Treatment include Pfizer, Roche, Teva, Virchow Laboratories, and Zhendong Group, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Antibiotics for Yersiniosis Treatment market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Aminoglycosides
Trimethoprim/sulfamethoxazole
Others
Market segment by Application can be divided into
Hospitals
Clinics
Others
The key market players for global Antibiotics for Yersiniosis Treatment market are listed below:
Pfizer
Roche
Teva
Virchow Laboratories
Zhendong Group
Datong Wuzhou Tong
PKU HealthCare Corp.
Jilin Wantong
Zhejiang Jinhua CONBA Bio-pharm
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Antibiotics for Yersiniosis Treatment product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Antibiotics for Yersiniosis Treatment, with price, sales, revenue and global market share of Antibiotics for Yersiniosis Treatment from 2019 to 2022.
Chapter 3, the Antibiotics for Yersiniosis Treatment competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Antibiotics for Yersiniosis Treatment breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Antibiotics for Yersiniosis Treatment market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Antibiotics for Yersiniosis Treatment.
Chapter 13, 14, and 15, to describe Antibiotics for Yersiniosis Treatment sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Antibiotics for Yersiniosis Treatment Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Antibiotics for Yersiniosis Treatment Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Aminoglycosides
1.2.3 Trimethoprim/sulfamethoxazole
1.2.4 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Antibiotics for Yersiniosis Treatment Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Antibiotics for Yersiniosis Treatment Market Size & Forecast
1.4.1 Global Antibiotics for Yersiniosis Treatment Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Antibiotics for Yersiniosis Treatment Sales in Volume (2017-2028)
1.4.3 Global Antibiotics for Yersiniosis Treatment Price (2017-2028)
1.5 Global Antibiotics for Yersiniosis Treatment Production Capacity Analysis
1.5.1 Global Antibiotics for Yersiniosis Treatment Total Production Capacity (2017-2028)
1.5.2 Global Antibiotics for Yersiniosis Treatment Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Antibiotics for Yersiniosis Treatment Market Drivers
1.6.2 Antibiotics for Yersiniosis Treatment Market Restraints
1.6.3 Antibiotics for Yersiniosis Treatment Trends Analysis
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Antibiotics for Yersiniosis Treatment Product and Services
2.1.4 Pfizer Antibiotics for Yersiniosis Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Roche
2.2.1 Roche Details
2.2.2 Roche Major Business
2.2.3 Roche Antibiotics for Yersiniosis Treatment Product and Services
2.2.4 Roche Antibiotics for Yersiniosis Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Teva
2.3.1 Teva Details
2.3.2 Teva Major Business
2.3.3 Teva Antibiotics for Yersiniosis Treatment Product and Services
2.3.4 Teva Antibiotics for Yersiniosis Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Virchow Laboratories
2.4.1 Virchow Laboratories Details
2.4.2 Virchow Laboratories Major Business
2.4.3 Virchow Laboratories Antibiotics for Yersiniosis Treatment Product and Services
2.4.4 Virchow Laboratories Antibiotics for Yersiniosis Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Zhendong Group
2.5.1 Zhendong Group Details
2.5.2 Zhendong Group Major Business
2.5.3 Zhendong Group Antibiotics for Yersiniosis Treatment Product and Services
2.5.4 Zhendong Group Antibiotics for Yersiniosis Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Datong Wuzhou Tong
2.6.1 Datong Wuzhou Tong Details
2.6.2 Datong Wuzhou Tong Major Business
2.6.3 Datong Wuzhou Tong Antibiotics for Yersiniosis Treatment Product and Services
2.6.4 Datong Wuzhou Tong Antibiotics for Yersiniosis Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 PKU HealthCare Corp.
2.7.1 PKU HealthCare Corp. Details
2.7.2 PKU HealthCare Corp. Major Business
2.7.3 PKU HealthCare Corp. Antibiotics for Yersiniosis Treatment Product and Services
2.7.4 PKU HealthCare Corp. Antibiotics for Yersiniosis Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Jilin Wantong
2.8.1 Jilin Wantong Details
2.8.2 Jilin Wantong Major Business
2.8.3 Jilin Wantong Antibiotics for Yersiniosis Treatment Product and Services
2.8.4 Jilin Wantong Antibiotics for Yersiniosis Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Zhejiang Jinhua CONBA Bio-pharm
2.9.1 Zhejiang Jinhua CONBA Bio-pharm Details
2.9.2 Zhejiang Jinhua CONBA Bio-pharm Major Business
2.9.3 Zhejiang Jinhua CONBA Bio-pharm Antibiotics for Yersiniosis Treatment Product and Services
2.9.4 Zhejiang Jinhua CONBA Bio-pharm Antibiotics for Yersiniosis Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Antibiotics for Yersiniosis Treatment Breakdown Data by Manufacturer
3.1 Global Antibiotics for Yersiniosis Treatment Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Antibiotics for Yersiniosis Treatment Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Antibiotics for Yersiniosis Treatment
3.4 Market Concentration Rate
3.4.1 Top 3 Antibiotics for Yersiniosis Treatment Manufacturer Market Share in 2021
3.4.2 Top 6 Antibiotics for Yersiniosis Treatment Manufacturer Market Share in 2021
3.5 Global Antibiotics for Yersiniosis Treatment Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Antibiotics for Yersiniosis Treatment Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Antibiotics for Yersiniosis Treatment Market Size by Region
4.1.1 Global Antibiotics for Yersiniosis Treatment Sales in Volume by Region (2017-2028)
4.1.2 Global Antibiotics for Yersiniosis Treatment Revenue by Region (2017-2028)
4.2 North America Antibiotics for Yersiniosis Treatment Revenue (2017-2028)
4.3 Europe Antibiotics for Yersiniosis Treatment Revenue (2017-2028)
4.4 Asia-Pacific Antibiotics for Yersiniosis Treatment Revenue (2017-2028)
4.5 South America Antibiotics for Yersiniosis Treatment Revenue (2017-2028)
4.6 Middle East and Africa Antibiotics for Yersiniosis Treatment Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Antibiotics for Yersiniosis Treatment Sales in Volume by Type (2017-2028)
5.2 Global Antibiotics for Yersiniosis Treatment Revenue by Type (2017-2028)
5.3 Global Antibiotics for Yersiniosis Treatment Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Antibiotics for Yersiniosis Treatment Sales in Volume by Application (2017-2028)
6.2 Global Antibiotics for Yersiniosis Treatment Revenue by Application (2017-2028)
6.3 Global Antibiotics for Yersiniosis Treatment Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Antibiotics for Yersiniosis Treatment Sales by Type (2017-2028)
7.2 North America Antibiotics for Yersiniosis Treatment Sales by Application (2017-2028)
7.3 North America Antibiotics for Yersiniosis Treatment Market Size by Country
7.3.1 North America Antibiotics for Yersiniosis Treatment Sales in Volume by Country (2017-2028)
7.3.2 North America Antibiotics for Yersiniosis Treatment Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Antibiotics for Yersiniosis Treatment Sales by Type (2017-2028)
8.2 Europe Antibiotics for Yersiniosis Treatment Sales by Application (2017-2028)
8.3 Europe Antibiotics for Yersiniosis Treatment Market Size by Country
8.3.1 Europe Antibiotics for Yersiniosis Treatment Sales in Volume by Country (2017-2028)
8.3.2 Europe Antibiotics for Yersiniosis Treatment Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Antibiotics for Yersiniosis Treatment Sales by Type (2017-2028)
9.2 Asia-Pacific Antibiotics for Yersiniosis Treatment Sales by Application (2017-2028)
9.3 Asia-Pacific Antibiotics for Yersiniosis Treatment Market Size by Region
9.3.1 Asia-Pacific Antibiotics for Yersiniosis Treatment Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Antibiotics for Yersiniosis Treatment Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Antibiotics for Yersiniosis Treatment Sales by Type (2017-2028)
10.2 South America Antibiotics for Yersiniosis Treatment Sales by Application (2017-2028)
10.3 South America Antibiotics for Yersiniosis Treatment Market Size by Country
10.3.1 South America Antibiotics for Yersiniosis Treatment Sales in Volume by Country (2017-2028)
10.3.2 South America Antibiotics for Yersiniosis Treatment Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Antibiotics for Yersiniosis Treatment Sales by Type (2017-2028)
11.2 Middle East & Africa Antibiotics for Yersiniosis Treatment Sales by Application (2017-2028)
11.3 Middle East & Africa Antibiotics for Yersiniosis Treatment Market Size by Country
11.3.1 Middle East & Africa Antibiotics for Yersiniosis Treatment Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Antibiotics for Yersiniosis Treatment Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Antibiotics for Yersiniosis Treatment and Key Manufacturers
12.2 Manufacturing Costs Percentage of Antibiotics for Yersiniosis Treatment
12.3 Antibiotics for Yersiniosis Treatment Production Process
12.4 Antibiotics for Yersiniosis Treatment Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Antibiotics for Yersiniosis Treatment Typical Distributors
13.3 Antibiotics for Yersiniosis Treatment Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Antibiotics for Yersiniosis Treatment Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Antibiotics for Yersiniosis Treatment Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Pfizer Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer Major Business
Table 5. Pfizer Antibiotics for Yersiniosis Treatment Product and Services
Table 6. Pfizer Antibiotics for Yersiniosis Treatment Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Roche Basic Information, Manufacturing Base and Competitors
Table 8. Roche Major Business
Table 9. Roche Antibiotics for Yersiniosis Treatment Product and Services
Table 10. Roche Antibiotics for Yersiniosis Treatment Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Teva Basic Information, Manufacturing Base and Competitors
Table 12. Teva Major Business
Table 13. Teva Antibiotics for Yersiniosis Treatment Product and Services
Table 14. Teva Antibiotics for Yersiniosis Treatment Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Virchow Laboratories Basic Information, Manufacturing Base and Competitors
Table 16. Virchow Laboratories Major Business
Table 17. Virchow Laboratories Antibiotics for Yersiniosis Treatment Product and Services
Table 18. Virchow Laboratories Antibiotics for Yersiniosis Treatment Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Zhendong Group Basic Information, Manufacturing Base and Competitors
Table 20. Zhendong Group Major Business
Table 21. Zhendong Group Antibiotics for Yersiniosis Treatment Product and Services
Table 22. Zhendong Group Antibiotics for Yersiniosis Treatment Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Datong Wuzhou Tong Basic Information, Manufacturing Base and Competitors
Table 24. Datong Wuzhou Tong Major Business
Table 25. Datong Wuzhou Tong Antibiotics for Yersiniosis Treatment Product and Services
Table 26. Datong Wuzhou Tong Antibiotics for Yersiniosis Treatment Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. PKU HealthCare Corp. Basic Information, Manufacturing Base and Competitors
Table 28. PKU HealthCare Corp. Major Business
Table 29. PKU HealthCare Corp. Antibiotics for Yersiniosis Treatment Product and Services
Table 30. PKU HealthCare Corp. Antibiotics for Yersiniosis Treatment Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Jilin Wantong Basic Information, Manufacturing Base and Competitors
Table 32. Jilin Wantong Major Business
Table 33. Jilin Wantong Antibiotics for Yersiniosis Treatment Product and Services
Table 34. Jilin Wantong Antibiotics for Yersiniosis Treatment Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Zhejiang Jinhua CONBA Bio-pharm Basic Information, Manufacturing Base and Competitors
Table 36. Zhejiang Jinhua CONBA Bio-pharm Major Business
Table 37. Zhejiang Jinhua CONBA Bio-pharm Antibiotics for Yersiniosis Treatment Product and Services
Table 38. Zhejiang Jinhua CONBA Bio-pharm Antibiotics for Yersiniosis Treatment Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Global Antibiotics for Yersiniosis Treatment Sales by Manufacturer (2019, 2020, 2021, and 2022) & (MT)
Table 40. Global Antibiotics for Yersiniosis Treatment Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 41. Market Position of Manufacturers in Antibiotics for Yersiniosis Treatment, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 42. Global Antibiotics for Yersiniosis Treatment Production Capacity by Company, (MT): 2020 VS 2021
Table 43. Head Office and Antibiotics for Yersiniosis Treatment Production Site of Key Manufacturer
Table 44. Antibiotics for Yersiniosis Treatment New Entrant and Capacity Expansion Plans
Table 45. Antibiotics for Yersiniosis Treatment Mergers & Acquisitions in the Past Five Years
Table 46. Global Antibiotics for Yersiniosis Treatment Sales by Region (2017-2022) & (MT)
Table 47. Global Antibiotics for Yersiniosis Treatment Sales by Region (2023-2028) & (MT)
Table 48. Global Antibiotics for Yersiniosis Treatment Revenue by Region (2017-2022) & (USD Million)
Table 49. Global Antibiotics for Yersiniosis Treatment Revenue by Region (2023-2028) & (USD Million)
Table 50. Global Antibiotics for Yersiniosis Treatment Sales by Type (2017-2022) & (MT)
Table 51. Global Antibiotics for Yersiniosis Treatment Sales by Type (2023-2028) & (MT)
Table 52. Global Antibiotics for Yersiniosis Treatment Revenue by Type (2017-2022) & (USD Million)
Table 53. Global Antibiotics for Yersiniosis Treatment Revenue by Type (2023-2028) & (USD Million)
Table 54. Global Antibiotics for Yersiniosis Treatment Price by Type (2017-2022) & (USD/Kg)
Table 55. Global Antibiotics for Yersiniosis Treatment Price by Type (2023-2028) & (USD/Kg)
Table 56. Global Antibiotics for Yersiniosis Treatment Sales by Application (2017-2022) & (MT)
Table 57. Global Antibiotics for Yersiniosis Treatment Sales by Application (2023-2028) & (MT)
Table 58. Global Antibiotics for Yersiniosis Treatment Revenue by Application (2017-2022) & (USD Million)
Table 59. Global Antibiotics for Yersiniosis Treatment Revenue by Application (2023-2028) & (USD Million)
Table 60. Global Antibiotics for Yersiniosis Treatment Price by Application (2017-2022) & (USD/Kg)
Table 61. Global Antibiotics for Yersiniosis Treatment Price by Application (2023-2028) & (USD/Kg)
Table 62. North America Antibiotics for Yersiniosis Treatment Sales by Country (2017-2022) & (MT)
Table 63. North America Antibiotics for Yersiniosis Treatment Sales by Country (2023-2028) & (MT)
Table 64. North America Antibiotics for Yersiniosis Treatment Revenue by Country (2017-2022) & (USD Million)
Table 65. North America Antibiotics for Yersiniosis Treatment Revenue by Country (2023-2028) & (USD Million)
Table 66. North America Antibiotics for Yersiniosis Treatment Sales by Type (2017-2022) & (MT)
Table 67. North America Antibiotics for Yersiniosis Treatment Sales by Type (2023-2028) & (MT)
Table 68. North America Antibiotics for Yersiniosis Treatment Sales by Application (2017-2022) & (MT)
Table 69. North America Antibiotics for Yersiniosis Treatment Sales by Application (2023-2028) & (MT)
Table 70. Europe Antibiotics for Yersiniosis Treatment Sales by Country (2017-2022) & (MT)
Table 71. Europe Antibiotics for Yersiniosis Treatment Sales by Country (2023-2028) & (MT)
Table 72. Europe Antibiotics for Yersiniosis Treatment Revenue by Country (2017-2022) & (USD Million)
Table 73. Europe Antibiotics for Yersiniosis Treatment Revenue by Country (2023-2028) & (USD Million)
Table 74. Europe Antibiotics for Yersiniosis Treatment Sales by Type (2017-2022) & (MT)
Table 75. Europe Antibiotics for Yersiniosis Treatment Sales by Type (2023-2028) & (MT)
Table 76. Europe Antibiotics for Yersiniosis Treatment Sales by Application (2017-2022) & (MT)
Table 77. Europe Antibiotics for Yersiniosis Treatment Sales by Application (2023-2028) & (MT)
Table 78. Asia-Pacific Antibiotics for Yersiniosis Treatment Sales by Region (2017-2022) & (MT)
Table 79. Asia-Pacific Antibiotics for Yersiniosis Treatment Sales by Region (2023-2028) & (MT)
Table 80. Asia-Pacific Antibiotics for Yersiniosis Treatment Revenue by Region (2017-2022) & (USD Million)
Table 81. Asia-Pacific Antibiotics for Yersiniosis Treatment Revenue by Region (2023-2028) & (USD Million)
Table 82. Asia-Pacific Antibiotics for Yersiniosis Treatment Sales by Type (2017-2022) & (MT)
Table 83. Asia-Pacific Antibiotics for Yersiniosis Treatment Sales by Type (2023-2028) & (MT)
Table 84. Asia-Pacific Antibiotics for Yersiniosis Treatment Sales by Application (2017-2022) & (MT)
Table 85. Asia-Pacific Antibiotics for Yersiniosis Treatment Sales by Application (2023-2028) & (MT)
Table 86. South America Antibiotics for Yersiniosis Treatment Sales by Country (2017-2022) & (MT)
Table 87. South America Antibiotics for Yersiniosis Treatment Sales by Country (2023-2028) & (MT)
Table 88. South America Antibiotics for Yersiniosis Treatment Revenue by Country (2017-2022) & (USD Million)
Table 89. South America Antibiotics for Yersiniosis Treatment Revenue by Country (2023-2028) & (USD Million)
Table 90. South America Antibiotics for Yersiniosis Treatment Sales by Type (2017-2022) & (MT)
Table 91. South America Antibiotics for Yersiniosis Treatment Sales by Type (2023-2028) & (MT)
Table 92. South America Antibiotics for Yersiniosis Treatment Sales by Application (2017-2022) & (MT)
Table 93. South America Antibiotics for Yersiniosis Treatment Sales by Application (2023-2028) & (MT)
Table 94. Middle East & Africa Antibiotics for Yersiniosis Treatment Sales by Region (2017-2022) & (MT)
Table 95. Middle East & Africa Antibiotics for Yersiniosis Treatment Sales by Region (2023-2028) & (MT)
Table 96. Middle East & Africa Antibiotics for Yersiniosis Treatment Revenue by Region (2017-2022) & (USD Million)
Table 97. Middle East & Africa Antibiotics for Yersiniosis Treatment Revenue by Region (2023-2028) & (USD Million)
Table 98. Middle East & Africa Antibiotics for Yersiniosis Treatment Sales by Type (2017-2022) & (MT)
Table 99. Middle East & Africa Antibiotics for Yersiniosis Treatment Sales by Type (2023-2028) & (MT)
Table 100. Middle East & Africa Antibiotics for Yersiniosis Treatment Sales by Application (2017-2022) & (MT)
Table 101. Middle East & Africa Antibiotics for Yersiniosis Treatment Sales by Application (2023-2028) & (MT)
Table 102. Antibiotics for Yersiniosis Treatment Raw Material
Table 103. Key Manufacturers of Antibiotics for Yersiniosis Treatment Raw Materials
Table 104. Direct Channel Pros & Cons
Table 105. Indirect Channel Pros & Cons
Table 106. Antibiotics for Yersiniosis Treatment Typical Distributors
Table 107. Antibiotics for Yersiniosis Treatment Typical Customers
List of Figures
Figure 1. Antibiotics for Yersiniosis Treatment Picture
Figure 2. Global Antibiotics for Yersiniosis Treatment Revenue Market Share by Type in 2021
Figure 3. Aminoglycosides
Figure 4. Trimethoprim/sulfamethoxazole
Figure 5. Others
Figure 6. Global Antibiotics for Yersiniosis Treatment Revenue Market Share by Application in 2021
Figure 7. Hospitals
Figure 8. Clinics
Figure 9. Others
Figure 10. Global Antibiotics for Yersiniosis Treatment Revenue, (USD Million) & (MT): 2017 & 2021 & 2028
Figure 11. Global Antibiotics for Yersiniosis Treatment Revenue and Forecast (2017-2028) & (USD Million)
Figure 12. Global Antibiotics for Yersiniosis Treatment Sales (2017-2028) & (MT)
Figure 13. Global Antibiotics for Yersiniosis Treatment Price (2017-2028) & (USD/Kg)
Figure 14. Global Antibiotics for Yersiniosis Treatment Production Capacity (2017-2028) & (MT)
Figure 15. Global Antibiotics for Yersiniosis Treatment Production Capacity by Geographic Region: 2022 VS 2028
Figure 16. Antibiotics for Yersiniosis Treatment Market Drivers
Figure 17. Antibiotics for Yersiniosis Treatment Market Restraints
Figure 18. Antibiotics for Yersiniosis Treatment Market Trends
Figure 19. Global Antibiotics for Yersiniosis Treatment Sales Market Share by Manufacturer in 2021
Figure 20. Global Antibiotics for Yersiniosis Treatment Revenue Market Share by Manufacturer in 2021
Figure 21. Antibiotics for Yersiniosis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 22. Top 3 Antibiotics for Yersiniosis Treatment Manufacturer (Revenue) Market Share in 2021
Figure 23. Top 6 Antibiotics for Yersiniosis Treatment Manufacturer (Revenue) Market Share in 2021
Figure 24. Global Antibiotics for Yersiniosis Treatment Sales Market Share by Region (2017-2028)
Figure 25. Global Antibiotics for Yersiniosis Treatment Revenue Market Share by Region (2017-2028)
Figure 26. North America Antibiotics for Yersiniosis Treatment Revenue (2017-2028) & (USD Million)
Figure 27. Europe Antibiotics for Yersiniosis Treatment Revenue (2017-2028) & (USD Million)
Figure 28. Asia-Pacific Antibiotics for Yersiniosis Treatment Revenue (2017-2028) & (USD Million)
Figure 29. South America Antibiotics for Yersiniosis Treatment Revenue (2017-2028) & (USD Million)
Figure 30. Middle East & Africa Antibiotics for Yersiniosis Treatment Revenue (2017-2028) & (USD Million)
Figure 31. Global Antibiotics for Yersiniosis Treatment Sales Market Share by Type (2017-2028)
Figure 32. Global Antibiotics for Yersiniosis Treatment Revenue Market Share by Type (2017-2028)
Figure 33. Global Antibiotics for Yersiniosis Treatment Price by Type (2017-2028) & (USD/Kg)
Figure 34. Global Antibiotics for Yersiniosis Treatment Sales Market Share by Application (2017-2028)
Figure 35. Global Antibiotics for Yersiniosis Treatment Revenue Market Share by Application (2017-2028)
Figure 36. Global Antibiotics for Yersiniosis Treatment Price by Application (2017-2028) & (USD/Kg)
Figure 37. North America Antibiotics for Yersiniosis Treatment Sales Market Share by Type (2017-2028)
Figure 38. North America Antibiotics for Yersiniosis Treatment Sales Market Share by Application (2017-2028)
Figure 39. North America Antibiotics for Yersiniosis Treatment Sales Market Share by Country (2017-2028)
Figure 40. North America Antibiotics for Yersiniosis Treatment Revenue Market Share by Country (2017-2028)
Figure 41. United States Antibiotics for Yersiniosis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Canada Antibiotics for Yersiniosis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Mexico Antibiotics for Yersiniosis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Europe Antibiotics for Yersiniosis Treatment Sales Market Share by Type (2017-2028)
Figure 45. Europe Antibiotics for Yersiniosis Treatment Sales Market Share by Application (2017-2028)
Figure 46. Europe Antibiotics for Yersiniosis Treatment Sales Market Share by Country (2017-2028)
Figure 47. Europe Antibiotics for Yersiniosis Treatment Revenue Market Share by Country (2017-2028)
Figure 48. Germany Antibiotics for Yersiniosis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. France Antibiotics for Yersiniosis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. United Kingdom Antibiotics for Yersiniosis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Russia Antibiotics for Yersiniosis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Italy Antibiotics for Yersiniosis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Asia-Pacific Antibiotics for Yersiniosis Treatment Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Antibiotics for Yersiniosis Treatment Sales Market Share by Application (2017-2028)
Figure 55. Asia-Pacific Antibiotics for Yersiniosis Treatment Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Antibiotics for Yersiniosis Treatment Revenue Market Share by Region (2017-2028)
Figure 57. China Antibiotics for Yersiniosis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Japan Antibiotics for Yersiniosis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Korea Antibiotics for Yersiniosis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. India Antibiotics for Yersiniosis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Southeast Asia Antibiotics for Yersiniosis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Australia Antibiotics for Yersiniosis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. South America Antibiotics for Yersiniosis Treatment Sales Market Share by Type (2017-2028)
Figure 64. South America Antibiotics for Yersiniosis Treatment Sales Market Share by Application (2017-2028)
Figure 65. South America Antibiotics for Yersiniosis Treatment Sales Market Share by Country (2017-2028)
Figure 66. South America Antibiotics for Yersiniosis Treatment Revenue Market Share by Country (2017-2028)
Figure 67. Brazil Antibiotics for Yersiniosis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Argentina Antibiotics for Yersiniosis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Middle East & Africa Antibiotics for Yersiniosis Treatment Sales Market Share by Type (2017-2028)
Figure 70. Middle East & Africa Antibiotics for Yersiniosis Treatment Sales Market Share by Application (2017-2028)
Figure 71. Middle East & Africa Antibiotics for Yersiniosis Treatment Sales Market Share by Region (2017-2028)
Figure 72. Middle East & Africa Antibiotics for Yersiniosis Treatment Revenue Market Share by Region (2017-2028)
Figure 73. Turkey Antibiotics for Yersiniosis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Egypt Antibiotics for Yersiniosis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Saudi Arabia Antibiotics for Yersiniosis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. South Africa Antibiotics for Yersiniosis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Manufacturing Cost Structure Analysis of Antibiotics for Yersiniosis Treatment in 2021
Figure 78. Manufacturing Process Analysis of Antibiotics for Yersiniosis Treatment
Figure 79. Antibiotics for Yersiniosis Treatment Industrial Chain
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Figure 81. Methodology
Figure 82. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界の経口用抗生物質市場2022年：市場規模予測（～2028年）
  • 世界のカルバペネム系抗生物質市場2022年：市場規模予測（～2028年）
  • 世界のペプチド抗生物質無菌注射剤市場2022年：市場規模予測（～2028年）
  • 世界のテトラサイクリン系抗生物質市場2022年：市場規模予測（～2028年）
  • 世界の吸入抗生物質市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19141 )"世界のエルシニア症治療用抗生物質市場2022年：市場規模予測（～2028年）" (英文：Global Antibiotics for Yersiniosis Treatment Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。